The board of directors of International Brand Licensing, the publicly quoted British company that owns the Admiral trade name, has decided that it should move away from the exploitation of its sports and lifestyle brands and re-direct its strategy toward in vitro diagnostic services.
Register a free account or login to unlock 3 more articles each week
SIGN-IN if you are already a subscriber of SGI Europe.

Already a subscriber? Sign in
Ready for unlimited coverage?
Upgrade to Professional or Premium for unlimited access to exclusive reports,
C-suite interviews, market analysis, and industry-wide research—with team licensing included.
Already registered? Sign in here